$WWR

URANIUM RESOURCES INC /DE/

CIK:0000839470|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Operating Expenses:
Product development expenses	$ (355)	$ (275)	$ (904)	$ (457)
Exploration expenses	(294)	(3)	(606)	(10)
General and administrative expenses	(3,558)	(3,133)	(7,100)	(5,427)
Mineral property expenses	(10)	(10)	(10)	(10)
Depreciation and amortization	(192)	(154)	(382)	(306)
Total operating expenses	(4,409)	(3,575)	(9,002)	(6,210)
Non-Operating Income (Expense):
Other income (expense), net	326	(294)	714	(335)
Total other income (expense), net	94	(294)	12	(335)
Net Loss	$ (4,315)	$ (3,869)	$ (8,990)	$ (6,545)
BASIC AND DILUTED LOSS PER SHARE
LOSS PER SHARE, BASIC (in dollars per share)	$ (0.03)	$ (0.05)	$ (0.07)	$ (0.09)
LOSS PER SHARE, DILUTED (in dollars per share)	$ (0.03)	$ (0.05)	$ (0.07)	$ (0.09)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING, BASIC (in shares)	126,877,023	75,983,998	124,736,340	71,974,217
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING, DILUTED (in shares)	126,877,023	75,983,998	124,736,340	71,974,217
Series A-1 Convertible Notes
Non-Operating Income (Expense):
Convertible Notes gain (loss)	$ (86)		$ 161
Series B-1 Convertible Notes
Non-Operating Income (Expense):
Convertible Notes gain (loss)	$ (146)		$ (863)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating Activities:
Net loss	$ (8,990)	$ (6,545)
Reconciliation of net loss to cash used in operations:
Non-cash lease expense	176	65
Depreciation and amortization	382	306
Stock compensation expense	1,593	932
Deferred contract costs write-off	259
Effect of changes in operating working capital items:
Other long-term assets	(551)	(270)
Prepaids and other current assets	(347)	(29)
Payables and accrued liabilities	228	868
Net Cash Used In Operating Activities	(6,548)	(4,673)
Investing Activities:
Capital expenditures	(2,283)	(5,057)
Proceeds from sale of assets		257
Net Cash Used In Investing Activities	(2,283)	(4,800)
Financing Activities:
Issuance of Common Stock, net of issuance costs	1,191	7,612
Payment of Series A-1 Convertible Notes issuance costs		(230)
Payment of debt issuance costs		(123)
Payment of minimum withholding taxes on net share settlements of equity awards	(2,731)	(351)
Payments on finance lease liabilities	(3)	(3)
Net Cash (Used In) Provided By Financing Activities	(1,543)	11,905
Net (decrease) increase in Cash and Cash Equivalents	(10,374)	2,432
Cash and Cash Equivalents, Beginning of Period	48,576	4,272
Cash and Cash Equivalents, End of Period	38,202	6,704
Supplemental Cash Flow Information
Accrued capital expenditures (at end of period)	466	3,242
Common Stock issued for Series B-1 Convertible Notes	4,438
Accrued debt issuance costs (at end of period)		1,629
Total Supplemental Cash Flow Information	4,904	4,871
Series A-1 Convertible Notes
Reconciliation of net loss to cash used in operations:
Convertible Notes (gain) loss	(161)
Financing Activities:
Proceeds from Convertible Notes		$ 5,000
Series B-1 Convertible Notes
Reconciliation of net loss to cash used in operations:
Convertible Notes (gain) loss	$ 863

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 38,202	$ 48,576
Prepaid and other current assets	641	294
Total Current Assets	38,843	48,870
Property, plant and equipment, at cost:
Property, plant and equipment	146,378	144,646
Less: Accumulated depreciation	(1,832)	(1,453)
Net property, plant and equipment	144,546	143,193
Other long-term assets	2,582	2,470
Total Assets	185,971	194,533
Current Liabilities:
Accounts payable	4,277	3,989
Accrued liabilities	1,048	1,660
Total Current Liabilities	7,563	11,622
Other long-term liabilities	1,378	1,382
Total Liabilities	8,941	13,004
Commitments and Contingencies (see Note 10)
Stockholders' Equity:
Common Stock, 400,000,000 shares authorized, $0.001 par value Issued shares - 128,564,994 and 117,989,625, respectively Outstanding shares - 128,564,833 and 117,989,464, respectively	129	118
Paid-in capital	587,161	582,681
Accumulated deficit	(410,002)	(401,012)
Less: Treasury stock (161 shares), at cost	(258)	(258)
Total Stockholders' Equity	177,030	181,529
Total Liabilities and Stockholders' Equity	185,971	194,533
Series A-1 Convertible Notes
Current Liabilities:
Convertible Notes	1,688	1,848
Series B-1 Convertible Notes
Current Liabilities:
Convertible Notes	$ 550	$ 4,125